Logo image of MBCN

MIDDLEFIELD BANC CORP (MBCN) Stock Fundamental Analysis

USA - NASDAQ:MBCN - US5963042040 - Common Stock

31.03 USD
+0.05 (+0.16%)
Last: 9/26/2025, 8:08:59 PM
Fundamental Rating

4

Taking everything into account, MBCN scores 4 out of 10 in our fundamental rating. MBCN was compared to 392 industry peers in the Banks industry. MBCN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MBCN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MBCN had positive earnings in the past year.
MBCN had a positive operating cash flow in the past year.
Each year in the past 5 years MBCN has been profitable.
MBCN had a positive operating cash flow in each of the past 5 years.
MBCN Yearly Net Income VS EBIT VS OCF VS FCFMBCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

MBCN has a Return On Assets of 0.94%. This is comparable to the rest of the industry: MBCN outperforms 57.65% of its industry peers.
MBCN's Return On Equity of 8.41% is in line compared to the rest of the industry. MBCN outperforms 50.26% of its industry peers.
Industry RankSector Rank
ROA 0.94%
ROE 8.41%
ROIC N/A
ROA(3y)0.91%
ROA(5y)0.94%
ROE(3y)7.91%
ROE(5y)8.47%
ROIC(3y)N/A
ROIC(5y)N/A
MBCN Yearly ROA, ROE, ROICMBCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

MBCN's Profit Margin of 24.95% is in line compared to the rest of the industry. MBCN outperforms 58.67% of its industry peers.
In the last couple of years the Profit Margin of MBCN has declined.
MBCN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 24.95%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.08%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
MBCN Yearly Profit, Operating, Gross MarginsMBCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

MBCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MBCN has less shares outstanding
MBCN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MBCN has an improved debt to assets ratio.
MBCN Yearly Shares OutstandingMBCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MBCN Yearly Total Debt VS Total AssetsMBCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MBCN has a debt to FCF ratio of 0.58. This is a very positive value and a sign of high solvency as it would only need 0.58 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.58, MBCN belongs to the best of the industry, outperforming 81.38% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that MBCN is not too dependend on debt financing.
MBCN has a Debt to Equity ratio of 0.05. This is amongst the best in the industry. MBCN outperforms 80.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.58
Altman-Z N/A
ROIC/WACCN/A
WACC13.98%
MBCN Yearly LT Debt VS Equity VS FCFMBCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MBCN Yearly Current Assets VS Current LiabilitesMBCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

MBCN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.56%, which is quite good.
The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
Looking at the last year, MBCN shows a small growth in Revenue. The Revenue has grown by 6.53% in the last year.
Measured over the past years, MBCN shows a small growth in Revenue. The Revenue has been growing by 7.99% on average per year.
EPS 1Y (TTM)18.56%
EPS 3Y-12.16%
EPS 5Y1.06%
EPS Q2Q%32.69%
Revenue 1Y (TTM)6.53%
Revenue growth 3Y7.02%
Revenue growth 5Y7.99%
Sales Q2Q%21.8%

3.2 Future

MBCN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.59% yearly.
The Revenue is expected to grow by 9.42% on average over the next years. This is quite good.
EPS Next Y30.13%
EPS Next 2Y12.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.23%
Revenue Next 2Y9.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MBCN Yearly Revenue VS EstimatesMBCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
MBCN Yearly EPS VS EstimatesMBCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.49, the valuation of MBCN can be described as correct.
MBCN's Price/Earnings is on the same level as the industry average.
MBCN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.32.
MBCN is valuated reasonably with a Price/Forward Earnings ratio of 12.00.
MBCN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MBCN is more expensive than 62.24% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.89, MBCN is valued a bit cheaper.
Industry RankSector Rank
PE 13.49
Fwd PE 12
MBCN Price Earnings VS Forward Price EarningsMBCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MBCN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 12.51
EV/EBITDA N/A
MBCN Per share dataMBCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

MBCN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MBCN's earnings are expected to grow with 12.59% in the coming years.
PEG (NY)0.45
PEG (5Y)12.7
EPS Next 2Y12.59%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.77%, MBCN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.52, MBCN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, MBCN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.77%

5.2 History

On average, the dividend of MBCN grows each year by 6.90%, which is quite nice.
MBCN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.9%
Div Incr Years0
Div Non Decr Years0
MBCN Yearly Dividends per shareMBCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

MBCN pays out 36.45% of its income as dividend. This is a sustainable payout ratio.
MBCN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP36.45%
EPS Next 2Y12.59%
EPS Next 3YN/A
MBCN Yearly Income VS Free CF VS DividendMBCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
MBCN Dividend Payout.MBCN Dividend Payout, showing the Payout Ratio.MBCN Dividend Payout.PayoutRetained Earnings

MIDDLEFIELD BANC CORP

NASDAQ:MBCN (9/26/2025, 8:08:59 PM)

31.03

+0.05 (+0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-15 2025-10-15/bmo
Inst Owners27.79%
Inst Owner Change2.3%
Ins Owners3.47%
Ins Owner Change1.29%
Market Cap250.72M
Analysts48.89
Price Target33.66 (8.48%)
Short Float %0.75%
Short Ratio7.53
Dividend
Industry RankSector Rank
Dividend Yield 2.77%
Yearly Dividend0.8
Dividend Growth(5Y)6.9%
DP36.45%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.21)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.07%
Min EPS beat(2)23.56%
Max EPS beat(2)28.58%
EPS beat(4)3
Avg EPS beat(4)17.23%
Min EPS beat(4)-11.17%
Max EPS beat(4)28.58%
EPS beat(8)5
Avg EPS beat(8)10.2%
EPS beat(12)8
Avg EPS beat(12)8.57%
EPS beat(16)12
Avg EPS beat(16)10.1%
Revenue beat(2)2
Avg Revenue beat(2)6.27%
Min Revenue beat(2)2.64%
Max Revenue beat(2)9.91%
Revenue beat(4)2
Avg Revenue beat(4)2.18%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)9.91%
Revenue beat(8)2
Avg Revenue beat(8)-0.82%
Revenue beat(12)4
Avg Revenue beat(12)-0.76%
Revenue beat(16)5
Avg Revenue beat(16)-0.69%
PT rev (1m)0%
PT rev (3m)16.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.51%
EPS NY rev (1m)0%
EPS NY rev (3m)17.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.27%
Valuation
Industry RankSector Rank
PE 13.49
Fwd PE 12
P/S 3.44
P/FCF 12.51
P/OCF 11.66
P/B 1.16
P/tB 1.44
EV/EBITDA N/A
EPS(TTM)2.3
EY7.41%
EPS(NY)2.59
Fwd EY8.33%
FCF(TTM)2.48
FCFY7.99%
OCF(TTM)2.66
OCFY8.58%
SpS9.02
BVpS26.74
TBVpS21.61
PEG (NY)0.45
PEG (5Y)12.7
Profitability
Industry RankSector Rank
ROA 0.94%
ROE 8.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 24.95%
GM N/A
FCFM 27.5%
ROA(3y)0.91%
ROA(5y)0.94%
ROE(3y)7.91%
ROE(5y)8.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.08%
PM growth 5Y-3.63%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.58
Debt/EBITDA N/A
Cap/Depr 108.92%
Cap/Sales 2.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 110.23%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC13.98%
ROIC/WACCN/A
Cap/Depr(3y)67.12%
Cap/Depr(5y)54.69%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.5%
Profit Quality(3y)113.84%
Profit Quality(5y)117.74%
High Growth Momentum
Growth
EPS 1Y (TTM)18.56%
EPS 3Y-12.16%
EPS 5Y1.06%
EPS Q2Q%32.69%
EPS Next Y30.13%
EPS Next 2Y12.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.53%
Revenue growth 3Y7.02%
Revenue growth 5Y7.99%
Sales Q2Q%21.8%
Revenue Next Year12.23%
Revenue Next 2Y9.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.43%
FCF growth 3Y4.07%
FCF growth 5Y7.62%
OCF growth 1Y-9.27%
OCF growth 3Y4.24%
OCF growth 5Y5.35%